Key points from article :
Actio Biosciences is a biotechnology company that uses precision medicine to develop drugs for rare and common diseases.
The company recently raised $55M to develop a drug for TRPV4, an ion channel involved in rare diseases.
Actio partnered with The Jackson Laboratory to develop transgenic models of rare diseases.
The company is led by experts in human genetics and drug discovery.
Actio aims to develop drugs for both rare and common diseases.
Actio is still in early stages, but has potential to impact treatment of many diseases.
